v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
SCHEDULE OF COMMON STOCK

The Company issued the following common stock during 2025 and 2024:

 

        Average Value 
Transaction Type  Shares Issued   Valuation $   Per Share 
2025 Equity Transactions               
Common stock issued, pursuant to services provided   6,368,231   $13,560,580   $2.13 
Common stock issued pursuant to stock at the market offering, net   4,243,123    5,424,368    1.28 
Common stock issued pursuant to preferred dividends   30,842    38,559    1.25 
Common stock issued pursuant to conversion of notes   272,728    600,000    2.20 
Common stock issued pursuant to conversion of accrued interest   433,073    615,291    1.42 
Common stock issued pursuant to exercise of options   1,001,492    420,000    0.42 
Common stock issued pursuant to conversion of preferred stock   1,958,336    2,550,000    1.30 
                
2024 Equity Transactions               
Common stock issued, pursuant to services provided   4,369,031   $13,474,433     0.82-1.78  
Common stock issued pursuant to stock at the market offering, net   3,535,067    4,330,295    0.91.64 
Common stock issued pursuant to exercise of options, net   128,023    7,501    - 
Common stock issued pursuant to acquisition   1,853,421    -    - 
SCHEDULE OF PREFERRED STOCK ACTIVITY

Transaction Type  Quantity   Carrying Value   Value per Share, gross 
Preferred Stock Balance at January 1, 2024   -   $-   $- 
Preferred Stock Series A   200,000    5,000,000    25 
Preferred Stock Series A-1   240,000    6,000,000    25 
Preferred Stock Balance at December 31, 2024   440,000   $11,000,000   $25 

 

During the year ended December 31, 2025, the Company authorized the issuance of 60,000 shares of a new series of preferred stock Series A-2. Details of activity in Preferred Stock Series A-1 and Series A-2 are as follows:

 

Transaction Type  Quantity   Carrying Value   Value per Share, gross 
Preferred Stock Series A-1 Balance at January 1, 2025   240,000   $6,000,000   $25 
Issuance   154,000    3,674,167    25 
Conversion to common stock   (102,000)   (2,550,000)   25 
Preferred Stock Series A-1 Balance at December 31, 2025   292,000   $7,124,167   $25 
                
Preferred Stock Series A-2 Balance at January 1, 2025   -   $-   $- 
Issuance   60,000    1,500,000    25 
Conversion to common stock   -    -    - 
Preferred Stock Series A-2 Balance at December 31, 2025   60,000   $1,500,000   $25 
SCHEDULE OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity during 2025 and 2024:

 

           Weighted     
           Average     
           Remaining     
       Weighted   Contractual   Aggregate 
       Average   Life   Intrinsic 
Options  Shares   Exercise Price   (In Years)   Value 
Outstanding, January 1, 2025   32,493,392   $7.31    2.45   $1,727,080 
Exercised   1,113,000   $0.70           
Granted   5,633,030    1.65    -    - 
Forfeited   (7,401,100)   (5.24)   -    - 
Outstanding, December  31, 2025   31,838,322   $6.81    2.12   $7,382,321 
                     
Exercisable, December  31, 2025   10,991,168   $4.56    2.51   $3,689,773 
                     
Outstanding, January 1, 2024   35,807,476   $7.33    -    - 
Exercised   135,000   $0.10    -   $- 
Granted   3,673,500    1.17    -    - 
Forfeited   (6,851,084)   4.25    -    6,112,000 
Outstanding, December 31, 2024   32,493,392   $7.31    2.45   $1,727,080 
                     
Exercisable, December 31, 2024   10,977,431   $4.40    2.25   $1,409,651 
SCHEDULE OF BLACK SCHOLES PRICING MODEL

The following table summarizes the range of the Black Scholes pricing model assumptions used by the Company during 2025 and 2024.

 

   December 31, 2025   December 31, 2024 
   Range 
         
Stock price   1.11 - 2.42    4.4 
Exercise price   0 - 14    0 - 14 
Expected life (in years)   2.50- 3.47 yrs.    2.50- 4.00 yrs. 
Volatility   101 110%    36.7 96.5% 
Risk-fee interest rate   3.56 - 4.02%    3.50 - 4.62% 
Dividend yield   -    - 
SCHEDULE OF WARRANT ACTIVITY

The following is a summary of the Company’s warrant activity during 2025 and 2024:

 

   Number of Warrants   Weighted Average
Exercise Price
 
         
Balance, January 1, 2025   1,523,667   $4.30 
Issued   64,750    1.2 
Exercised   -    - 
Forfeited   -    - 
Balance, December  31, 2025   1,588,417   $4.19 
           
Balance, January 1, 2024   2,063,522   $5.76 
Issued        
Exercised        
Forfeited   (539,885)   9.8 
Balance, December 31, 2024   1,523,667   $4.30 
SCHEDULE OF NON-VESTED RESTRICTED STOCK

A summary of the Company’s non-vested restricted stock units during 2025 and 2024 are as follows.

 

      Weighted 
       Average Grant 
   Shares   Due Fair Value 
Non-vested restricted stock units, January 1, 2025   6,278,370   $2.65 
Granted   6,537,012    1.39 
Vested   (6,655,463)   1.60 
Forfeited   (1,171,102)   5.36 
Non-vested restricted stock units, December  31, 2025   4,988,817   $1.76 
           
Non-vested restricted stock units, January 1, 2024   4,935,822   $7.99 
Granted   6,168,980    1.12 
Vested   (4,513,527)   2.27 
Forfeited   (312,905)   2.58 
Non-vested restricted stock units on December 31, 2024   6,278,370   $2.65